ANTX
AN2 Therapeutics Inc
5.00$
-1.8%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| -0.13 | -0.29 | -1.09 | -2.18 | -2.26 | -1.65 | -0.99 | |
| – | – | – | -0.05 | – | – | – | |
| – | 0.00 | 0.05 | 0.29 | 0.36 | 0.28 | 0.21 | |
| 1.01 | 0.37 | 0.05 | 0.25 | – | – | – | |
| 0.00 | 0.07 | 0.00 | 0.24 | 0.25 | -0.10 | 0.01 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -2.67 | -2.67 | -2.67 | -1.42 | -1.83 | 1.83 | 0.94 | |
| – | – | – | 0.12 | – | – | – | |
| – | – | – | 0.00 | – | – | – | |
| 0.43 | 0.20 | 4.19 | 4.59 | 3.60 | 0.01 | 0.00 | |
| 0.30 | -0.08 | 0.43 | 0.99 | -0.49 | 0.19 | -0.05 | |
| -0.13 | -0.29 | -1.09 | -2.18 | -2.26 | -1.65 | -0.99 |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.